Divisions of Endocrinology, Metabolism and Diabetes, and Cardiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, and Department of Laboratory Medicine and Pathology, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, WA, USA.
Cell Metab. 2021 Aug 3;33(8):1519-1545. doi: 10.1016/j.cmet.2021.07.001. Epub 2021 Jul 21.
Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.
尽管人们早在几十年前就已经认识到糖尿病是心血管疾病的一个主要危险因素,但这种关联的原因仍不完全清楚。虽然这种关联对 1 型和 2 型糖尿病都适用,但可能有不同的病理生理过程在起作用。脂质和其他危险因素确实很重要,而葡萄糖的作用则不那么明确。这种不明确性源于临床试验并未明确表明强化血糖控制可减少心血管事件。动物模型提供了将糖尿病与动脉粥样硬化增加联系起来的机制,并且出现了与高血糖以外的因素的重要性一致的证据。我们回顾了探索糖尿病患者和糖尿病小鼠模型中动脉粥样硬化发病机制的临床、病理和动物研究。现在需要加大努力来识别除葡萄糖以外的危险因素,以预防与糖尿病相关的心血管疾病风险增加。